View the LOPID registration information details.
Back to drug list
ItemsDrug Registration information
ID524
No524
Brand NameLOPID
IngredientsGEMFIBROZIL 300 MG
Dosage FormCAPSULE
Primary PackagingPVC-ALU BLISTER
Storage
Shelf Life60 MONTHS
Pack SizeBOX OF 10 X 10'S
Dispensing Category
ATC Classification
Pharmaceutical Class
IndicationsGEMFIBROZIL IS A LIPID REGULATIONG AGENT THAT IS INDICATED FOR THE FOLLOWING : PRIMARY PREVENTION OF CORONARY HEART DISEASE (CHD) AND MYOCARDIAL INFARCTION (MI) IN PATIENTS WITH HYPERCHOLESTEROLEMIA, MIXED DYSLIPIDEMIA AND HYPERTRIGLYCERIDEMIA, FREDRICKSON'S CLASSIFICATION TYPES IIA, IIB AND IV.
Contraindications
Side Effects
Unit Price
EDLNULL
DescriptionNO. 0 SNAP-FIT HARD GELATIN CAPSULES, WHITE OPAQUE BODY AND D-SCARLET OPAQUE CAP, BOVINE IMPRINTING-AXIAL ''PD 669'' AND ''LOPID TM'' IN GRAY CONTAINING A WHITE WAXY POWDER.
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerOLIC (THAILAND) LIMITED
CountryTHAILAND
Import Registration No
Import Registration Date
ActivityCERTIFICATE RELEASED
Applied Date
FDD Registration No07 I 4016/14
FDD Registration Date22/06/2024
Expiry Date21/06/2027
Back to drug list
ADB ASEAN COVID-19 Laos JICA KOICA Global Fund WFP UHS Laos World Bank MOH Laos UNODC WHO SIDA